Butovsky believes xenon has potential as an AD treatment. A Phase 1 clinical trial of xenon at BWH is recruiting healthy elderly volunteers to test safety and effects on immune cells. “I hope this ...

In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped reduce levels of brain atrophy and neuroinflammation.

Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a $3 billion market cap pharmaceutical company specializing in the development of therapeutic drugs, announced today the departure of its Chief Commercial ...

Enron, or the satire-infused Frankenstein version of the long-deceased company, filed an application Tuesday to become Texas’ ...

Quantum computing stocks just got hit with another setback. On Jan. 10, Meta Platforms (META) CEO Mark Zuckerberg cast doubt ...